California SB 17: New Requirements for Drug Manufacturers

California SB 17: New Requirements for Drug Manufacturers

October 11, 2017, Covington Alert

On Monday, October 9, 2017, California Governor Jerry Brown signed into law Senate Bill 17 (SB 17), establishing substantial new reporting and notification requirements in California for prescription drug manufacturers related to drug pricing. California is the latest of several states to enact legislation related to drug pricing. This alert, prepared by Covington's California and D.C.-based attorneys, summarizes the key provisions of the new California law that are most relevant to pharmaceutical companies.